May 7 |
Elevation Oncology to Present at the Citizens JMP Life Sciences Conference
|
May 3 |
Elevation Oncology: Mid-2024 EO-3021 Data Could Get Ball Rolling
|
May 2 |
Elevation Oncology files for $350M mixed shelf
|
May 2 |
Elevation Oncology GAAP EPS of -$0.23
|
May 2 |
Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements
|
Apr 22 |
Elevation Oncology: Continuing To Seek Footing As It Climbs (Rating Upgrade)
|
Apr 11 |
7 Top Stocks Under $7
|
Apr 8 |
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
|
Mar 7 |
Elevation Oncology Inc (ELEV) Reports Financial Results for Q4 and Full Year 2023
|
Mar 6 |
Top 10 best performing biotech stocks of 2024 so far
|